1. Home
  2. BLAC vs SER Comparison

BLAC vs SER Comparison

Compare BLAC & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLAC
  • SER
  • Stock Information
  • Founded
  • BLAC 2020
  • SER 2017
  • Country
  • BLAC United States
  • SER United States
  • Employees
  • BLAC N/A
  • SER N/A
  • Industry
  • BLAC
  • SER Biotechnology: Pharmaceutical Preparations
  • Sector
  • BLAC
  • SER Health Care
  • Exchange
  • BLAC NYSE
  • SER Nasdaq
  • Market Cap
  • BLAC 26.3M
  • SER 44.8M
  • IPO Year
  • BLAC 2023
  • SER 2018
  • Fundamental
  • Price
  • BLAC $11.42
  • SER $4.60
  • Analyst Decision
  • BLAC
  • SER
  • Analyst Count
  • BLAC 0
  • SER 0
  • Target Price
  • BLAC N/A
  • SER N/A
  • AVG Volume (30 Days)
  • BLAC 6.2K
  • SER 18.4K
  • Earning Date
  • BLAC 01-01-0001
  • SER 11-12-2024
  • Dividend Yield
  • BLAC N/A
  • SER N/A
  • EPS Growth
  • BLAC N/A
  • SER N/A
  • EPS
  • BLAC N/A
  • SER N/A
  • Revenue
  • BLAC N/A
  • SER $3,157,500.00
  • Revenue This Year
  • BLAC N/A
  • SER N/A
  • Revenue Next Year
  • BLAC N/A
  • SER N/A
  • P/E Ratio
  • BLAC N/A
  • SER N/A
  • Revenue Growth
  • BLAC N/A
  • SER 2454.55
  • 52 Week Low
  • BLAC $10.56
  • SER $3.81
  • 52 Week High
  • BLAC $13.40
  • SER $23.18
  • Technical
  • Relative Strength Index (RSI)
  • BLAC 50.56
  • SER 44.15
  • Support Level
  • BLAC $11.27
  • SER $4.60
  • Resistance Level
  • BLAC $11.50
  • SER $5.00
  • Average True Range (ATR)
  • BLAC 0.31
  • SER 0.29
  • MACD
  • BLAC -0.02
  • SER 0.01
  • Stochastic Oscillator
  • BLAC 14.86
  • SER 0.52

About BLAC BELLEVUE LIFE SCIENCES ACQ CORP

Bellevue Life Sciences Acquisition Corp is a blank check company.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.

Share on Social Networks: